Business Wire

ALIPAY+

16.12.2022 05:08:36 CET | Business Wire | Press release

Share
Over 1 Million Global Merchants Join Alipay+ to Provide Special Holiday Offers to Users of Five Asian e-Wallets

Alipay+, the provider of global cross-border digital payments and marketing solutions, today rolled out its first year-end promotion campaign with merchants across Asia and Europe, in collaboration with five Asian e-wallet partners - AlipayHK (Hong Kong SAR, China), GCash (Philippines), Kakao Pay (South Korea), TrueMoney (Thailand) and Touch ‘n Go eWallet (Malaysia).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221215006131/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Great in-destination merchant offers are available where Alipay+ operates, including Japan, South Korea, Singapore and various countries in Europe. (Graphic: Business Wire)

The promotion campaign sees the participation of over one million merchants in retail, F&B, tourist attractions and hospitality across major travel destinations where Alipay+ is accepted, including Japan, South Korea, Singapore, and various countries in Europe. During the campaign period, users of participating e-wallets can enjoy a wide range of deals offered by Alipay+ together with merchant partners in each destination.

Leveraging the Alipay+ marketing solutions, merchants are able to create and customize promotions in the forms of either digital coupons or instant discounts. Merchants can also distribute digital coupons in multiple e-wallet apps at the same time to achieve better marketing efficiency and scalability.

Japan

Between 15 December 2022 and 15 February 2023, users of AlipayHK, GCash, Kakao Pay, TrueMoney and Touch ’n Go eWallet will receive three coupons in their respective apps upon arrival in Japan. Each of the three coupons offers a ¥50 discount with a minimum of ¥51 spent, and can be redeemed at all local merchants accepting Alipay+ payments across Japan.

In addition, Alipay+ has also introduced other merchant-specific coupons. Such offers include, but are not limited to:

  • ¥1,000 OFF with a minimum of ¥5,000 spent at merchants such as Daimaru Department Store, Keio Department Store, Kintetsu Department Store, merchants at Fukuoka Airport, BicCamera stores, and many others.
  • ¥500 OFF with a minimum of ¥3,000 spent at merchants such as Tsuruha Drug Store, Sapporo Drug Store, and many others.

E-wallet users are able to access and browse all merchant-specific coupons in their respective apps.

Through the integration of Alipay+ solutions, over one million brick-and-mortar merchants in Japan including airports, shopping malls, convenience stores, cafes, and restaurants are now able to accept various mobile payment methods.

South Korea

From now till the end of December, users of AlipayHK, GCash, TrueMoney and Touch ‘n Go eWallet can redeem digital coupons by simply using the respective e-wallets to scan the Alipay+ in-store promotion QR code displayed at the store cashiers, and enjoy instant discounts of up to 10%, when they pay with their e-wallets via Alipay+ at local merchants.

Participating merchants include F&B brands like Paris Baguette, Haidilao, retailers such as Daiso, Galleria Department Store, as well as Lotte Duty Free, Shinsegae Duty Free, etc. Over 120,000 merchants in South Korea are now accept the payments made by these four e-wallets via Alipay+.

Singapore

From now till 31 January 2023, users of AlipayHK, GCash, Kakao Pay, TrueMoney and Touch ’n Go eWallet will be given three coupons upon arrival in Singapore and enjoy savings when shopping in Singapore.

  • Coupon 1: SGD 1 off with a minimum of SGD 1.01 spent
  • Coupon 2: SGD 3 off with a minimum of SGD 3.01 spent
  • Coupon 3: SGD 8 off with a minimum of SGD 100 spent

Furthermore, Alipay+ has extended more promotions with various merchants at Changi Airport and Paragon Shopping Centre. Between 15 December 2022 and 31 January 2023, e-wallet users can enjoy three more deals:

  • Coupon 1: SGD 5 off with a minimum of SGD 20 spent;
  • Coupon 2: SGD 10 off with a minimum of SGD 100 spent;
  • Coupon 3: SGD 18 off with a minimum of SGD 200 spent.

When taking a ComfortDelgro Taxi in Singapore, users can also claim SGD 2 off with a minimum spending of SGD 2.01.

Each e-wallet user can redeem up to three coupons during the campaign period.

Europe

In France, UK, Italy and Germany, Alipay+ has rolled out various promotions and deals with local merchants, including retail stores Printemps in France and city-wide vending machines in Milan, Rome and Venice to reward shoppers this holiday season.

Between now and 31 January 2023, users of Kakao Pay, GCash, TrueMoney and Touch ‘n Go eWallet can enjoy up to 10 EUR in instant discounts when paying with the respective e-wallets at the aforementioned merchants. In addition, Printemps in France is also offering e-wallet users a special 5% store-wide discount and a free bubble tea voucher at the Printemps Haussmann store. E-wallet users can visit the store information desks to check for specific details.

As of November 2022, Alipay+’s merchant coverage has reached 2.5 million. Its merchant network includes regional and global digital entertainment providers, lifestyle services, e-commerce platforms and a wide range of brick-and-mortar businesses that cover major airports, shopping centers, duty free shops, convenience stores, cafes, restaurants and tourism facilities.

The global merchant coverage of Alipay+ by sector includes over 1,000 online platforms, more than 10 major airports, over 90,000 convenience stores, over 360,000 restaurants, nearly 200,000 taxis and major hotel brands, department stores, duty-free shops and tourist facilities in Asia and Europe.

*Terms and conditions apply in coupon usage and redemption.

About Alipay+

Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221215006131/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye